Aditi G Muddebihalkar
Overview
Explore the profile of Aditi G Muddebihalkar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khangwal I, Skariyachan S, Uttarkar A, Muddebihalkar A, Niranjan V, Shukla P
Mol Biotechnol
. 2021 Sep;
64(1):75-89.
PMID: 34542815
Xylooligosaccharides having various degrees of polymerization such as xylobiose, xylotriose, and xylotetraose positively affect human health by interacting with gut proteins. The present study aimed to identify proteins present in...
2.
Skariyachan S, Gopal D, Muddebihalkar A, Uttarkar A, Niranjan V
Comput Biol Med
. 2021 Mar;
132:104325.
PMID: 33751995
Though significant efforts are in progress for developing drugs and vaccines against COVID-19, limited therapeutic agents are available currently. Thus, it is essential to undertake COVID-19 research and to identify...
3.
Skariyachan S, Gopal D, Chakrabarti S, Kempanna P, Uttarkar A, Muddebihalkar A, et al.
Comput Biol Med
. 2020 Oct;
126:104054.
PMID: 33074111
The repurposing of FDA approved drugs is presently receiving attention for COVID-19 drug discovery. Previous studies revealed the binding potential of several FDA-approved drugs towards specific targets of SARS-CoV-2; however,...
4.
Skariyachan S, Ravishankar R, Gopal D, Muddebihalkar A, Uttarkar A, Praveen P, et al.
Infect Genet Evol
. 2020 Jul;
85:104448.
PMID: 32622078
Pseudomonas aeruginosa has become a global concern due to its extreme resistance to most of the last resort antibiotics. Present study focuses on the screening of potential molecular targets involved...
5.
Skariyachan S, Muddebihalkar A, Badrinath V, Umashankar B, Eram D, Uttarkar A, et al.
Infect Genet Evol
. 2020 Apr;
82:104314.
PMID: 32268193
The current study aimed to identify putative drug targets of multidrug resistant Acinetobacter baumannii (MDRAb) and study the therapeutic potential of natural epiestriol-16 by computer aided virtual screening and in...
6.
Skariyachan S, Gopal D, Kadam S, Muddebihalkar A, Uttarkar A, Niranjan V
J Biomol Struct Dyn
. 2020 Feb;
39(3):1121-1137.
PMID: 32036742
This study aimed to screen putative drug targets associated with biofilm formation of multidrug-resistant and and prioritize carbon nano-fullerene as potential lead molecule by structure-based virtual screening. Based on the...
7.
Gopal D, Muddebihalkar A, Skariyachan S, C A, Kaveramma P, Praveen U, et al.
J Biomol Struct Dyn
. 2019 Oct;
38(15):4584-4599.
PMID: 31625462
, fungal yeast causes several lethal infections in immune-suppressed patients and recently emerged as drug-resistant pathogens worldwide. The present study aimed to screen putative drug targets of and to study...